TCTR20240611001招募中3 期
SAFETY AND EFFECTIVENESS OF OXYRESVERATROL CREAM IN HEALTHY VOLUNTEERS AND PATIENT WITH DERMATITIS
Ratchadapisek Research Fund - Type 20 个研究点目标入组 40 人开始时间: 2024年6月11日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1. Diagnosis with acute to subacute eczema by dermatologist at OPD King Chulalongkorn Memorial hospital 2. At least 1 lesion of acute to subacute eczema with mild severity with 0-12 Eczema Area and Severity Index score
排除标准
- •1. wide-spread systemic skin diseases 2. other skin lesion at the area of study 3. history of ORV allergy 4. pregnant or lactation 5. received topical immunosuppressant or corticosteroid within 2 weeks 6. received oral immunosuppressant or corticosteroid within 4 weeks 7. received live vaccine or immunotherapy within 4 weeks 8. patients with cancer or autoimmune disease
研究者
相似试验
进行中（未招募）
不适用
CLINICAL EFFICACY AND SAFETY OFTAZAROTENE CREAM 0.05% IN THE INITIALAND MAINTENANCE THERAPIES OF LAMELLAR ICHTHYOSIS (LI)amellar Ichtyosis (LI)EUCTR2010-022284-35-ATOrfagen80
进行中（未招募）
1 期
CLINICAL EFFICACY AND SAFETY OFTAZAROTENE CREAM 0.05% IN THE INITIALAND MAINTENANCE THERAPIES OF LAMELLAR ICHTHYOSIS (LI)amellar Ichtyosis (LI)EUCTR2010-022284-35-FROrfagen80
进行中（未招募）
不适用
CLINICAL EFFICACY AND SAFETY OFTAZAROTENE CREAM 0.05% IN THE INITIALAND MAINTENANCE THERAPIES OF LAMELLAR ICHTHYOSIS (LI)amellar Ichtyosis (LI)EUCTR2010-022284-35-SEOrfagen80
进行中（未招募）
不适用
CLINICAL EFFICACY AND SAFETY OFTAZAROTENE CREAM 0.05% IN THE INITIALAND MAINTENANCE THERAPIES OF LAMELLAR ICHTHYOSIS (LI)amellar Ichtyosis (LI)EUCTR2010-022284-35-DEOrfagen80
进行中（未招募）
不适用
EFFICACY AND SAFETY OF ORAL OCTREOLIN™ IN PATIENTS WITH ACROMEGALYMedDRA version: 14.1Level: PTClassification code 10000599Term: AcromegalySystem Organ Class: 10014698 - Endocrine disordersAcromegalyEUCTR2011-002912-10-SIChiasma, Inc.150